Litcius/Paper detail

Long noncoding RNA MIR4435-2HG enhances metabolic function of myeloid dendritic cells from HIV-1 elite controllers

Ciputra Adijaya Hartana, Yelizaveta Rassadkina, Ce Gao, Enrique Martín‐Gayo, Bruce D. Walker, Mathias Lichterfeld, Xu G. Yu

2021Journal of Clinical Investigation44 citationsDOIOpen Access PDF

Abstract

Restriction of HIV-1 replication in elite controllers (ECs) is frequently attributed to T cell-mediated immune responses, while the specific contribution of innate immune cells is less clear. Here, we demonstrate an upregulation of the host long noncoding RNA (lncRNA) MIR4435-2HG in primary myeloid dendritic cells (mDCs) from ECs. Elevated expression of this lncRNA in mDCs was associated with a distinct immunometabolic profile, characterized by increased oxidative phosphorylation and glycolysis activities in response to TLR3 stimulation. Using functional assays, we show that MIR4435-2HG directly influenced the metabolic state of mDCs, likely through epigenetic mechanisms involving H3K27ac enrichment at an intronic enhancer in the RPTOR gene locus, the main component of the mammalian target of rapamycin complex 1 (mTORC1). Together, these results suggest a role of MIR4435-2HG for enhancing immunometabolic activities of mDCs in ECs through targeted epigenetic modifications of a member of the mTOR signaling pathway.

Topics & Concepts

BiologyCell biologyEpigeneticsInnate immune systemImmune systemmTORC1MyeloidDownregulation and upregulationPI3K/AKT/mTOR pathwayCancer researchImmunologySignal transductionGeneGeneticsImmune Cell Function and InteractionCancer-related molecular mechanisms researchHIV Research and Treatment
Long noncoding RNA MIR4435-2HG enhances metabolic function of myeloid dendritic cells from HIV-1 elite controllers | Litcius